Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/16/25 | EFFECT | Notice of Effectiveness |
|
1 |
